Skip to content
Review Open access

Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis

Nov 2026 · Biochemical Society Transactions · Vol 54, pp. 1581 - 1594 · 0 citations · 131 references
Medicine

TL;DR

Insight from recent DMS studies of α-synuclein are highlighted, which have implicated membrane binding as an important contribution to its toxicity and aggregation, and experiments in different cell types reveal distinct determinants of aggregation.

Abstract

Abstract The abundant neuronal protein α-synuclein is a key driver of Parkinson’s and related diseases. α-Synuclein adopts a wide variety of different conformational states, but it is often unclear which of these species is responsible for its various behaviors, complicating efforts to combat pathologic misfolding of α-synuclein. Whereas conventional approaches struggle to provide direct, high-resolution insight into these structure–activity relationships, deep mutational scanning (DMS) has recently emerged as a powerful approach to probe the structural basis of protein activity and identify the molecular determinants of pathology. In the present review, we highlight insights from recent DMS studies of α-synuclein, which have implicated membrane binding as an important contribution to its toxicity and aggregation. Further, experiments in different cell types reveal distinct determinants of aggregation, highlighting the role of the cellular environment in shaping the conformational landscape of α-synuclein. We therefore expect that DMS will fill an important gap in the characterization of protein structure–activity relationships, particularly for conformationally dynamic proteins, including those implicated in misfolding diseases.

Read PDF

Similar papers

Open access Sep 2026

Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation

Heterotypic interactions with Aβ42 reshape α-syn aggregation pathways and fibril conformations, generating structurally distinct α-syn fibril populations with different neuronal seeding activities, which provide a molecular framework for understanding how cross-talk between amyloidogenic proteins may contribute to stru...

Purnopama Saha, Teshani Liyanaarachchige, Anika Alim et al. · 0 citations
Open access Oct 2026

Thrombin reshapes α-synuclein biochemical properties by N-terminal truncation

It is shown that thrombin, a serine protease associated with inflammatory conditions, selectively cleaves α-Synuclein at Lys6–Gly7, generating a 7–140 fragment despite the presence of multiple potential cleavage sites.

Philipp Trolese, Benedetta Fongaro, Alberto Benetollo et al. · 0 citations
Open access Oct 2026

Hsp10 Targets the C-Terminus of α-Synuclein to Inhibit Secondary Nucleation and Remodel Labile Fibrils

Aggregation of α-synuclein is a central pathological feature of Parkinson’s disease and related synucleinopathies. The co-chaperonin Hsp10, a component of the Hsp60/Hsp10 chaperonin system, has recently been proposed to possess independent chaperone activity and has been found to co-localize with α-synuclein aggregates...

Muhammed Shafeek Oliyantakath Hassan, S. Call, Ayobami T. Adegbenro et al. · 0 citations
Review Open access Nov 2026

Alpha-synuclein pathobiology and therapeutic targeting in Parkinson’s disease

The reviewed evidence indicates that α-Syn pathobiology arises from the interplay of conformational plasticity, molecular interactions, PTMs, and impaired cellular proteostasis, and the need to move beyond reducing α-Syn burden toward selectively preventing pathogenic conformations while preserving its physiological fu...

Sina Reyhani, Mozhgan Alipour, Behnam Hajipour-Verdom et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.